1. Home
  2. LCID vs BHVN Comparison

LCID vs BHVN Comparison

Compare LCID & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$5.55

Market Cap

2.0B

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$16.56

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
BHVN
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
LCID
BHVN
Price
$5.55
$16.56
Analyst Decision
Hold
Buy
Analyst Count
7
14
Target Price
$15.71
$29.08
AVG Volume (30 Days)
13.1M
3.6M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
$595,271,000.00
N/A
Revenue This Year
$71.67
N/A
Revenue Next Year
$89.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$7.48
52 Week High
$25.22
$18.57

Technical Indicators

Market Signals
Indicator
LCID
BHVN
Relative Strength Index (RSI) 47.85 76.57
Support Level $4.47 $8.54
Resistance Level $5.53 $18.37
Average True Range (ATR) 0.37 0.99
MACD 0.07 0.42
Stochastic Oscillator 92.13 95.38

Price Performance

Historical Comparison
LCID
BHVN

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: